Cargando…
Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants
PURPOSE: To assess the binding of the PET tracer [(18)F]THK5351 in patients with different primary progressive aphasia (PPA) variants and its correlation with clinical deficits. The majority of patients with nonfluent variant (NFV) and logopenic variant (LV) PPA have underlying tauopathy of the fron...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208807/ https://www.ncbi.nlm.nih.gov/pubmed/29946950 http://dx.doi.org/10.1007/s00259-018-4075-3 |
_version_ | 1783366781810769920 |
---|---|
author | Schaeverbeke, Jolien Evenepoel, Charlotte Declercq, Lieven Gabel, Silvy Meersmans, Karen Bruffaerts, Rose Adamczuk, Kate Dries, Eva Van Bouwel, Karen Sieben, Anne Pijnenburg, Yolande Peeters, Ronald Bormans, Guy Van Laere, Koen Koole, Michel Dupont, Patrick Vandenberghe, Rik |
author_facet | Schaeverbeke, Jolien Evenepoel, Charlotte Declercq, Lieven Gabel, Silvy Meersmans, Karen Bruffaerts, Rose Adamczuk, Kate Dries, Eva Van Bouwel, Karen Sieben, Anne Pijnenburg, Yolande Peeters, Ronald Bormans, Guy Van Laere, Koen Koole, Michel Dupont, Patrick Vandenberghe, Rik |
author_sort | Schaeverbeke, Jolien |
collection | PubMed |
description | PURPOSE: To assess the binding of the PET tracer [(18)F]THK5351 in patients with different primary progressive aphasia (PPA) variants and its correlation with clinical deficits. The majority of patients with nonfluent variant (NFV) and logopenic variant (LV) PPA have underlying tauopathy of the frontotemporal lobar or Alzheimer disease type, respectively, while patients with the semantic variant (SV) have predominantly transactive response DNA binding protein 43-kDa pathology. METHODS: The study included 20 PPA patients consecutively recruited through a memory clinic (12 NFV, 5 SV, 3 LV), and 20 healthy controls. All participants received an extensive neurolinguistic assessment, magnetic resonance imaging and amyloid biomarker tests. [(18)F]THK5351 binding patterns were assessed on standardized uptake value ratio (SUVR) images with the cerebellar grey matter as the reference using statistical parametric mapping. Whole-brain voxel-wise regression analysis was performed to evaluate the association between [(18)F]THK5351 SUVR images and neurolinguistic scores. Analyses were performed with and without partial volume correction. RESULTS: Patients with NFV showed increased binding in the supplementary motor area, left premotor cortex, thalamus, basal ganglia and midbrain compared with controls and patients with SV. Patients with SV had increased binding in the temporal lobes bilaterally and in the right ventromedial frontal cortex compared with controls and patients with NFV. The whole-brain voxel-wise regression analysis revealed a correlation between agrammatism and motor speech impairment, and [(18)F]THK5351 binding in the left supplementary motor area and left postcentral gyrus. Analysis of [(18)F]THK5351 scans without partial volume correction revealed similar results. CONCLUSION: [(18)F]THK5351 imaging shows a topography closely matching the anatomical distribution of predicted underlying pathology characteristic of NFV and SV PPA. [(18)F]THK5351 binding correlates with the severity of clinical impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-018-4075-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6208807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-62088072018-11-09 Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants Schaeverbeke, Jolien Evenepoel, Charlotte Declercq, Lieven Gabel, Silvy Meersmans, Karen Bruffaerts, Rose Adamczuk, Kate Dries, Eva Van Bouwel, Karen Sieben, Anne Pijnenburg, Yolande Peeters, Ronald Bormans, Guy Van Laere, Koen Koole, Michel Dupont, Patrick Vandenberghe, Rik Eur J Nucl Med Mol Imaging Original Article PURPOSE: To assess the binding of the PET tracer [(18)F]THK5351 in patients with different primary progressive aphasia (PPA) variants and its correlation with clinical deficits. The majority of patients with nonfluent variant (NFV) and logopenic variant (LV) PPA have underlying tauopathy of the frontotemporal lobar or Alzheimer disease type, respectively, while patients with the semantic variant (SV) have predominantly transactive response DNA binding protein 43-kDa pathology. METHODS: The study included 20 PPA patients consecutively recruited through a memory clinic (12 NFV, 5 SV, 3 LV), and 20 healthy controls. All participants received an extensive neurolinguistic assessment, magnetic resonance imaging and amyloid biomarker tests. [(18)F]THK5351 binding patterns were assessed on standardized uptake value ratio (SUVR) images with the cerebellar grey matter as the reference using statistical parametric mapping. Whole-brain voxel-wise regression analysis was performed to evaluate the association between [(18)F]THK5351 SUVR images and neurolinguistic scores. Analyses were performed with and without partial volume correction. RESULTS: Patients with NFV showed increased binding in the supplementary motor area, left premotor cortex, thalamus, basal ganglia and midbrain compared with controls and patients with SV. Patients with SV had increased binding in the temporal lobes bilaterally and in the right ventromedial frontal cortex compared with controls and patients with NFV. The whole-brain voxel-wise regression analysis revealed a correlation between agrammatism and motor speech impairment, and [(18)F]THK5351 binding in the left supplementary motor area and left postcentral gyrus. Analysis of [(18)F]THK5351 scans without partial volume correction revealed similar results. CONCLUSION: [(18)F]THK5351 imaging shows a topography closely matching the anatomical distribution of predicted underlying pathology characteristic of NFV and SV PPA. [(18)F]THK5351 binding correlates with the severity of clinical impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-018-4075-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-06-26 2018 /pmc/articles/PMC6208807/ /pubmed/29946950 http://dx.doi.org/10.1007/s00259-018-4075-3 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Schaeverbeke, Jolien Evenepoel, Charlotte Declercq, Lieven Gabel, Silvy Meersmans, Karen Bruffaerts, Rose Adamczuk, Kate Dries, Eva Van Bouwel, Karen Sieben, Anne Pijnenburg, Yolande Peeters, Ronald Bormans, Guy Van Laere, Koen Koole, Michel Dupont, Patrick Vandenberghe, Rik Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants |
title | Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants |
title_full | Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants |
title_fullStr | Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants |
title_full_unstemmed | Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants |
title_short | Distinct [(18)F]THK5351 binding patterns in primary progressive aphasia variants |
title_sort | distinct [(18)f]thk5351 binding patterns in primary progressive aphasia variants |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208807/ https://www.ncbi.nlm.nih.gov/pubmed/29946950 http://dx.doi.org/10.1007/s00259-018-4075-3 |
work_keys_str_mv | AT schaeverbekejolien distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT evenepoelcharlotte distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT declercqlieven distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT gabelsilvy distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT meersmanskaren distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT bruffaertsrose distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT adamczukkate distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT drieseva distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT vanbouwelkaren distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT siebenanne distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT pijnenburgyolande distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT peetersronald distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT bormansguy distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT vanlaerekoen distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT koolemichel distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT dupontpatrick distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants AT vandenbergherik distinct18fthk5351bindingpatternsinprimaryprogressiveaphasiavariants |